Pharmaceutical Campaign Planning: A Step-by-Step Process

Most campaign delays in pharma are not caused by any one step being slow. They come from steps happening out of order. Creative gets built before the audience is final. The measurement partner is called after the media is live and the holdout is impossible. The media plan assumes a format MLR has never approved. This process puts the steps in the order that avoids those rework loops.

The ten steps of pharmaceutical campaign planning

1. Set the objective. One business objective tied to the brand plan: increase new patient starts among a segment, support a new indication, defend share in a region. Write it as a change in behavior, not as "awareness."
2. Define the audience. HCP segments (with the NPI list source and refresh date), patient or caregiver audiences, and any exclusions. The target marketing in pharma article covers how to prioritize.
3. Set KPIs and measurement design. Choose the outcome metric, the comparison method (holdout, matched market, or modeled), and the readout date. Contract the measurement partner now.
4. Set the budget. Working media, nonworking costs (data, tech, measurement, creative), and a learning reserve for tests.
5. Write the brief. One document partners can execute from. See how to write a pharma programmatic brief.
6. Build the media plan. Channels, partners, flighting, frequency goals, and the job each line has.
7. Develop creative. Sized for the formats in the plan, with required safety information designed in from the first draft.
8. Clear MLR and privacy review. Creative, landing pages, targeting approach, and tracking all reviewed. Plan at least two rounds.
9. Prelaunch QA and launch. Tags, list uploads, frequency caps, ISI rendering, and measurement feeds confirmed before spend starts.
10. Optimize and read out. Weekly optimization against agreed rules, a midpoint check, and a final readout with a scale, hold, or stop recommendation.

The programmatic version of steps 6 through 10, with more detail on in-flight decisions, is in the pharma programmatic campaign planning and optimization guide.

A working timeline

The timeline below is illustrative for a new campaign on an in-market brand with an existing agency, existing data contracts, and a familiar set of formats. A launch, a new indication, or a new agency will run longer.

Note the overlap between creative and MLR. Showing concepts to reviewers informally before formal submission is the single most effective way I know to shorten the schedule.

Why measurement design comes in step three

If you want to know whether a campaign changed prescribing, you need a group that did not see it. For HCP media, that usually means holding out a random slice of the NPI list before launch. For DTC, it can mean matched markets or a measurement partner's modeled control. None of this can be added after the fact without weakening the result.

Prescription data also lag. Claims take weeks to arrive, and most attribution windows run 30 to 90 days or longer after exposure. That is why the readout in the table lands 6 to 12 weeks after the flight ends. Plan the decision date around it, or the brand will make next year's budget call on clicks.

What MLR needs from the media team

MLR reviewers are evaluating claims, fair balance, and context. They are not media experts, and they review faster when the submission answers their questions up front:

• Every format and size, with mockups showing how the ISI or safety information appears in each.
• Where the ads will run (endemic sites, open web, social, CTV) and any context restrictions.
• What happens on click, with the landing page for each creative.
• For dynamic or modular creative, every possible combination or the rules that govern them.
• For social, the comment moderation and adverse event monitoring plan.

More on getting faster approvals is in MLR review for programmatic media.

What usually goes wrong

• The objective is "awareness." Then every result counts as success and nothing can be cut.
• The target list changes after creative is approved. If the new list adds a specialty, the messaging may need review again.
• QA is rushed because MLR ran late. Broken ISI rendering or missing tags in week one cost more than a launch delay of a few days.
• The readout has no recommendation. A deck of charts with no decision is not a readout.

Where this fits

This process sits inside a broader strategy. The choices about market, audience, and positioning come first, as laid out in pharmaceutical marketing strategies. A launch follows the same steps on a much longer clock, covered in the drug launch media plan.

Practical takeaway

Take your next campaign launch date and count back 20 weeks. Write the gate for each step in the timeline table on a calendar, with an owner's name next to it. If the measurement partner gate falls after the creative gate, move it forward now.

Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.